Full Text
PCN2- DOSES OF OLANZPINE, RISPERIDONE, AND HALOPERIDOL IN CLINICAL PRACTICE- RESULTS OF A PROSPECTIVE PHARMACOEOPIDEMIOGICAL STUDY (EFESO)

Abstract

Authors

JA Sacristn JC Gmez KJ Gregor AL Montejo E Vieta

Back to Volume 2, Issue 5
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×